WhiteLab Genomics
YC W22 · Active · Unleashing the potential of DNA and RNA based therapies using AI
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW18 | |
| Other | Active | YCW17 | |
| Other | Inactive | YCW20 | |
| Other | Active | YCW23 | |
| Other | Active | YCW17 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW19 | |
| AI | Active | YCS21 | |
| Other | Active | YCS21 | |
| AI | Active | YCF25 | |
| Other | Active | YCW22 |
Also from W22 in AI
All of W22About WhiteLab Genomics
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
- YC batch
- W22 · Winter 2022
- Status, per YC
- Active
- Category
- AI
- Team size
- 40
- Location
- Paris, Île-de-France, France; Boston, MA, USA
- Checked
- 35m ago
YC tags: Artificial Intelligence, Gene Therapy, Cell Therapy, Genomics
WhiteLab Genomics: questions
Which YC batch was WhiteLab Genomics in?
WhiteLab Genomics was in Y Combinator's Winter 2022 batch (W22).
Is WhiteLab Genomics still active?
Y Combinator lists WhiteLab Genomics as active.
Where is WhiteLab Genomics based?
WhiteLab Genomics lists Paris, Île-de-France, France; Boston, MA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.